101 related articles for article (PubMed ID: 8580830)
1. Abnormalities of retinoblastoma gene expression in hematological malignancies.
Zhu YM; Haynes AP; Keith FJ; Russell NH
Leuk Lymphoma; 1995 Jun; 18(1-2):61-7. PubMed ID: 8580830
[TBL] [Abstract][Full Text] [Related]
2. The retinoblastoma gene (RB-1) status in multiple myeloma: a report on 35 cases.
Zandecki M; Facon T; Preudhomme C; Vanrumbeke M; Vachee A; Quesnel B; Lai JL; Cosson A; Fenaux P
Leuk Lymphoma; 1995 Aug; 18(5-6):497-503. PubMed ID: 8528059
[TBL] [Abstract][Full Text] [Related]
3. [Abnormalities of the retinoblastoma susceptibility gene (RB) in hematologic malignancies].
Furukawa Y
Nihon Rinsho; 1992 Jun; 50(6):1347-52. PubMed ID: 1518156
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the retinoblastoma gene in human lymphoid neoplasms.
Ginsberg AM; Raffeld M; Cossman J
Leuk Lymphoma; 1992 Aug; 7(5-6):359-62. PubMed ID: 1493437
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the retinoblastoma gene in human lymphoid neoplasms.
Ginsberg AM; Raffeld M; Cossman J
Blood; 1991 Feb; 77(4):833-40. PubMed ID: 1993222
[TBL] [Abstract][Full Text] [Related]
6. The retinoblastoma susceptibility gene RB-1 in multiple myeloma.
Juge-Morineau N; Harousseau JL; Amiot M; Bataille R
Leuk Lymphoma; 1997 Jan; 24(3-4):229-37. PubMed ID: 9156653
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the retinoblastoma gene in multiple myeloma.
Dao DD; Sawyer JR; Epstein J; Hoover RG; Barlogie B; Tricot G
Leukemia; 1994 Aug; 8(8):1280-4. PubMed ID: 8057662
[TBL] [Abstract][Full Text] [Related]
8. High incidence of deletions but infrequent inactivation of the retinoblastoma gene in human myeloma cells.
Juge-Morineau N; Mellerin MP; Francois S; Rapp MJ; Harousseau JL; Amiot M; Bataille R
Br J Haematol; 1995 Nov; 91(3):664-7. PubMed ID: 8555072
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization and cytogenetics of hemopoietic malignancies: new developments.
Cherif D; Berger R
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):45-7. PubMed ID: 8511041
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal abnormalities in human neoplasia.
Sandberg AA; Hossfeld DK
Annu Rev Med; 1970; 21():379-408. PubMed ID: 4247449
[No Abstract] [Full Text] [Related]
11. [Methylation of p16 gene with pathogenesis of lymphocytic and plasmacytic malignancies].
Wang MM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1126-9. PubMed ID: 17956705
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma gene family expression in lymphoid tissues.
Leoncini L; Bellan C; De Falco G
Oncogene; 2006 Aug; 25(38):5309-14. PubMed ID: 16936752
[TBL] [Abstract][Full Text] [Related]
13. Heredity and cancer in man.
Knudson AG; Strong LC; Anderson DE
Prog Med Genet; 1973; 9():113-58. PubMed ID: 4351406
[No Abstract] [Full Text] [Related]
14. [Tumor suppressor genes and their role in abnormal production of leukocytes (leukemogenesis)].
Furukawa Y
Rinsho Ketsueki; 1993 May; 34(5):572-7. PubMed ID: 8315827
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome abnormalities during chronic lymphoid leukemia, malignant lymphoreticular process and Kahler's disease].
Broustet A; Meuge C; Legrand E
Nouv Rev Fr Hematol; 1970; 10(1):91-9. PubMed ID: 4246339
[No Abstract] [Full Text] [Related]
16. The retinoblastoma gene and gene product.
Weinberg RA
Cancer Surv; 1992; 12():43-57. PubMed ID: 1638547
[TBL] [Abstract][Full Text] [Related]
17. [Chromosome abnormalities in hematological diseases].
Jensen MK
Ugeskr Laeger; 1976 Mar; 138(11):657-60. PubMed ID: 1062867
[No Abstract] [Full Text] [Related]
18. Familial (inherited) leukemia, lymphoma, and myeloma: an overview.
Segel GB; Lichtman MA
Blood Cells Mol Dis; 2004; 32(1):246-61. PubMed ID: 14757442
[TBL] [Abstract][Full Text] [Related]
19. Chromosomes in plasma-cell malignancies.
Van Den Berghe H
Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.
Tsai T; Davalath S; Rankin C; Radich JP; Head D; Appelbaum FR; Boldt DH
Leukemia; 1996 Dec; 10(12):1901-10. PubMed ID: 8946929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
